[Federal Register Volume 76, Number 5 (Friday, January 7, 2011)]
[Notices]
[Page 1150]
[FR Doc No: 2011-40]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. NJ11-6-000]

City of Anaheim, CA; Notice of Filing

December 30, 2010.
    Take notice that on December 17, 2010, the City of Anaheim,
California (Anaheim) filed its annual revision to its Transmission
Revenue Balancing Account Adjustment, consistent with its Transmission
Owner Tariff filed in Docket No. EL03-15-000, and the California
Independent System Operator Corporation Tariff.
    Anaheim also requests any necessary waivers by the Commission to
allow its filing to be accepted for filing and approved by the
Commission to become effective as of January 1, 2011.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 pm Eastern Time on January 18, 2011.

Kimberly D. Bose,
Secretary.
[FR Doc. 2011-40 Filed 1-6-11; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: December 6, 2007 (Volume 72, Number 234)]
[Notices]
[Page 68879-68880]
[DOCID:fr06de07-52]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OAR-2007-0529; FRL-8502-8]

Agency Information Collection Activities; Submission to OMB for
Review and Approval; Comment Request; ENERGY STAR[supreg] Product
Labeling (Renewal); EPA ICR No. 2078.02, OMB Control No. 2060-0528

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (PRA)(44 U.S.C.
3501 et seq.), this document announces that an Information Collection
Request (ICR) has been forwarded to the Office of Management and Budget
(OMB) for review and approval. This is a request to renew an existing
approved collection. The ICR, which is abstracted below, describes the
nature of the information collection and its estimated burden and cost.

DATES: Additional comments may be submitted on or before January 7,
2008.

ADDRESSES: Submit your comments, referencing Docket ID No. EPA-HQ-OAR-
2007-0529, to (1) EPA online using http://www.regulations.gov (our preferred method), by email to<EMAIL_ADDRESS>or by mail to:

EPA Docket Center, Environmental Protection Agency, Air and Radiation
Docket, Mailcode: 2822T, 1200 Pennsylvania Ave., NW., Washington, DC
20460, and (2) OMB by mail to: Office of Information and Regulatory
Affairs, Office of Management and Budget (OMB), Attention: Desk Officer
for EPA, 725 17th Street, NW., Washington, DC 20503.

FOR FURTHER INFORMATION CONTACT: Rachel Schmeltz, Climate Protection
Partnerships Division, Office of Air and Radiation, Mailcode 6202J,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460; telephone number:<PHONE_NUMBER>; fax number: 202-
343-2200; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: EPA has submitted the following ICR to OMB
for review and approval according to the procedures prescribed in 5 CFR
1320.12. On July 13, 2007 (72 FR 38573), EPA sought comments on this
ICR pursuant to 5 CFR 1320.8(d). EPA received no comments. Any
additional comments on this ICR should be submitted to EPA and OMB
within 30 days of this notice.
    EPA has established a public docket for this ICR under Docket ID
No. EPA-HQ-OAR-2007-0529 which is available for online viewing at
http://www.regulations.gov, or in person viewing at the Air and

Radiation Docket in the EPA Docket Center (EPA/DC), EPA West, Room
3334, 1301 Constitution Ave., NW., Washington, DC. The EPA/DC Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Reading
Room is<PHONE_NUMBER>, and the telephone number for the Air and
Radiation Docket is<PHONE_NUMBER>.
    Use EPA's electronic docket and comment system at http://www.regulations.gov
, to submit or view public comments, access the

index listing of the contents of the docket, and to access those
documents in the docket that are available electronically. Once in the
system, select ``docket search,'' then key in the docket ID number
identified above. Please note that EPA's policy is that public
comments, whether submitted electronically or in paper, will be made
available for public

viewing at http://www.regulations.gov as EPA receives them and without

change, unless the comment contains copyrighted material, Confidential
Business Information (CBI), or other information whose public
disclosure is restricted by statute. For further information about the
electronic docket, go to http://www.regulations.gov.

    Title: ENERGY STAR[supreg] Product Labeling (Renewal).
    ICR numbers: EPA ICR No. 2078.02, OMB Control No. 2060-0528.
    ICR Status: This ICR is scheduled to expire on December 31, 2007.
Under OMB regulations, the Agency may continue to conduct or sponsor
the collection of information while this submission is pending at OMB.
An Agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information, unless it displays a currently
valid OMB control number. The OMB control numbers for EPA's regulations
in title 40 of the CFR, after appearing in the Federal Register when
approved, are listed in 40 CFR part 9, are displayed either by
publication in the Federal Register or by other appropriate means, such
as on the related collection instrument or form, if applicable. The
display of OMB control numbers in certain EPA regulations is
consolidated in 40 CFR part 9.
    Abstract: ENERGY STAR is a voluntary program developed in
collaboration with industry to create a self-sustaining market for
energy efficient products. The centerpiece of the program is the ENERGY
STAR label, a registered certification label that helps consumers
identify products that save energy, save money, and help protect the
environment without sacrificing quality or performance. In order to
protect the integrity of the label and enhance its effectiveness in the
marketplace, EPA must ensure that products carrying the label meet
appropriate program requirements. Since ENERGY STAR is a self-
certification program, it is important that program participants submit
signed Partnership Agreements indicating that they will adhere to logo-
use guidelines and that participating products meet specified energy
performance criteria based on a standard test method.
    As part of our contribution to the overall success of the program,
EPA has agreed to facilitate the sale of qualifying products by
providing consumers with easy-to-use information about the products. To
be effective, EPA must receive qualifying product information from
participating manufacturers. Partners are requested to submit updates
to qualifying product information on an annual basis, at minimum, so as
to ensure that EPA information is recent and accurate. The information
will be compiled into a complete qualifying product list per product
category, posted on the ENERGY STAR Web site, and supplied to those
purchasers who request it via phone, fax, or e-mail. In addition,
because of the nature of these products, manufacturers of roof products
and residential light fixtures are requested to submit testing reports
in order to verify qualification.
    In order to monitor progress and support the best allocation of
resources, EPA also asks manufacturers to submit annual shipment data
for the ENERGY STAR qualifying products. EPA is flexible as to the
methods by which manufacturers may submit unit shipment data. For
example, if manufacturers already submit this type of information to a
third party, such as a trade association, they are given the option of
arranging for shipment data to be sent to EPA via this third party to
avoid duplication of efforts and to ensure confidentiality. In using
any shipment data received directly from a partner, EPA will mask the
source of the data so as to protect confidentiality.
    Finally, Partners that wish to receive recognition for their
efforts in ENERGY STAR may submit an application for the Partner of the
Year award.
    Burden Statement: The annual public reporting and recordkeeping
burden for this collection of information is estimated to average 89.33
hours per response. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, or
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; develop, acquire,
install, and utilize technology and systems for the purposes of
collecting, validating, and verifying information, processing and
maintaining information, and disclosing and providing information;
adjust the existing ways to comply with any previously applicable
instructions and requirements which have subsequently changed; train
personnel to be able to respond to a collection of information; search
data sources; complete and review the collection of information; and
transmit or otherwise disclose the information.
    Respondents/Affected Entities: Respondents for this information
collection request include Partners in ENERGY STAR. Partners are
product manufacturers.
    Estimated Number of Respondents: 692.
    Frequency of Response: Initially/one-time and annually.
    Estimated Total Annual Hour Burden: 89,150 hours.
    Estimated Total Annual Cost: $7,056,533, includes $238,831
annualized capital or O&M costs.
    Changes in the Estimates: There is an increase of 18,483 hours in
the total estimated burden currently identified in the OMB Inventory of
Approved ICR Burdens. Although the estimated burden for each individual
collection decreased, the overall increase in burden hours reflects the
increased number of ENERGY STAR qualified roof products and residential
light fixtures for which Partners are required to submit testing
reports along with qualifying product information. The currently
approved ICR estimated 654 submissions, whereas this ICR estimates
4,464 submissions for this activity. This change is an adjustment to
the burden estimates.

    Dated: November 29, 2007.
Sara Hisel-McCoy,
Director, Collections Strategies Division.
[FR Doc. E7-23652 Filed 12-5-07; 8:45 am]

BILLING CODE 6560-50-P


8506 Federal Register / Vol. 68, No. 35 / Friday, February 21, 2003 / Notices [ FR Doc. 03   4075 Filed 2   20   03; 8: 45 am]

BILLING CODE 4000   01   P ENVIRONMENTAL PROTECTION AGENCY [ ER   FRL   6637   8]

Environmental Impact Statements; Notice of Availability Responsible Agency: Office of Federal Activities, General Information ( 202) 564   7167 or http:// www. epa. gov/ compliance/ nepa/. Weekly receipt of Environmental Impact Statements filed February 10, 2003, through February 14, 2003, pursuant to 40 CFR 1506.9. EIS No. 030054, Draft Supplement, BLM, WY, Jack Morrow Hills Coordinated Activity Plan/ Draft Green River Resource Management Plan Amendment, Updated Information, Rock Springs, Portions of Sweetwater, Fremont and Subelette Counties, WY, Comment Period Ends: May 15, 2003, Contact: Joe Patti ( 307) 775   6101. This document is available on the Internet at: http:// www. wy. blm. com. EIS No. 030057, Draft Supplement, FHW, FL, FL   23 Extension ( Branan Field   Chaffee Road), Construction from FL   134 ( 103rd Street) to FL   8 ( I   10) and FL   10 ( US   90/ Beaver Street), NPDES and US Army COE Section 404 Permits Issuance, FM No. 209659   1 and FAP No. 9041   047   C, Clay and Duval Counties, FL, Comment Period Ends: April 7, 2003, Contact: Jose Pena ( 850) 942   9650 Ext. 3033. EIS No. 230058, Final EIS, FHW, SC, James E. Clyburn Connector Project, Construction of a Two Lane Rural Roadway Northeast of Orangeburg and Southwest of Sumter, Funding and U. S. Army COE Section 404 Permit Issuance, Calhoun, Sumter and Claredon Counties, SC, Wait Period Ends: April 1, 2003, Contact: Daniel T. Hinton ( 803) 253   3887. EIS No. 030059, Final Supplement, NPS, ID, MT, WY, MT, WY, Yellowstone and Grand Teton National Parks and John D. Rockerfeller, Jr., Memorial Parkway, Winter Use Plans, Updated and New Information on New Generation of Snowmobiles that Produce fewer Emissions and are Quieter, Fremont County, ID, Gallatin and Park Counties, MT and Park and Teton Counties, WY, Wait Period Ends: March 24, 2003, Contact: Madeleine VanderHeyden ( 307) 739   3385. EIS No. 030060, Final EIS, FTA, NV, Las Vegas Resort Corridor Project, Transportation Improvements, Funding, City of Las Vegas, Clark County, NV, Wait Period Ends: March 24, 2003, Contact: Ray Sukys ( 415) 744   3115. EIS No. 030061, Final EIS, FHW, CA, Butte 70/ 149/ 99/ 191 Highway Improvement Project, Update State Route 149 to Four Lane Expressway from 70 North of Oroville to Route 99 South of Chico, Funding, Right of Way Acquisition, and U. S. Army Section 404 Permit Issuance, Butte County, CA, Wait Period Ends: March 24, 2003, Contact: Maiser Khaled ( 916) 498   5020. EIS No. 030062, Draft EIS, AFS, MT, Sheep Creek Range Analysis, Proposal to Reorganize Grazing and Special Use Allotments, Grazing and Special Use Permits Issue, Lewis and Clark National Forest, White Sulphur Springs Ranger District, Meagher and Cascade Counties, MT, Comment Period Ends: April 7, 2003, Contact: Eldon Rash ( 406) 791   7706. EIS No. 030063, Draft EIS, FHW, MT, Interstate 15 Corridor Project, Transportation Improvements from Montana City to the Lincoln Road Interchange, Funding and U. S. Army COE Section 404 Permit Issuance, Jefferson and Lewis & Clark Counties, MT, Comment Period Ends: April 7, 2003, Contact: Carl James ( 406) 449   5302. EIS No. 030064, Final EIS, FHW, IL, U. S. 34/ FAP 313 Transportation Facility Improvement Project, U. S. 34 from the Intersection of Carman Road east of Gulfport to Monmouth, Funding and U. S. Army COE Section 404 and NPDES Permits Issuance, Henderson and Warren Counties, IL, Wait Period Ends: March 24, 2003, Contact: Norman R. Stoner ( 217) 492   4600.

Dated: February 19, 2003. Joseph C. Montgomery, Director, NEPA Compliance Division, Office of Federal Activities. [ FR Doc. 03   4299 Filed 2   20   03; 8: 45 am]

BILLING CODE 6560   50   P ENVIRONMENTAL PROTECTION AGENCY [ OPPT   2003   0003; FRL   7291   4]

National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances; Notice of Public Meeting AGENCY: Environmental Protection Agency ( EPA). ACTION: Notice.

SUMMARY: A meeting of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances ( NAC/ AEGL) Committee will be held on March 7 8, 2003, in Salt Lake City, Utah. At this meeting, the NAC/ AEGL Committee will address, as time permits, the various aspects of the acute toxicity and the development of AEGLs for the following chemicals: Acetone, boron trifluoride, carbon disulfide, formaldehyde, hydrogen bromide, iron pentacarbonyl, nitric acid, piperidine, titanium tetrachloride, and vinyl chloride.

DATES: A meeting of the NAC/ AEGL Committee will be held from 8 a. m. to 5 p. m. on March 7, 2003, and 8 a. m. to 5 p. m. on March 8, 2003.

ADDRESSES: The meeting will be held at the Eagle Gate East and West, Best Western Salt Lake Plaza Hotel, 122 West South Temple, Salt Lake City, Utah.

FOR FURTHER INFORMATION CONTACT: For general information contact: Barbara Cunningham, Acting Director, Environmental Assistance Division ( 7408M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460   0001; telephone number: ( 202) 554   1404; e mail address: TSCA Hotline@ epa. gov. For technical information contact: Paul S. Tobin, Designated Federal Officer ( DFO), Economics, Exposure, and Technology Division ( 7406M), Office of Pollution Prevention and Toxics, 1200 Pennsylvania Ave., NW., Washington, DC 20460   0001; telephone number: ( 202) 564   8557; e mail address: tobin. paul@ epa. gov.

SUPPLEMENTARY INFORMATION:

I. General Information A. Does This Action Apply to Me?

This action is directed to the public in general. This action may be of particular interest to anyone who may be affected if the AEGL values are adopted by government agencies for emergency planning, prevention, or response programs, such as EPA's Risk Management Program under the Clean Air Act and Amendments Section 112r. It is possible that other Federal agencies besides EPA, as well as State agencies and private organizations, may adopt the AEGL values for their programs. As such, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the DFO listed under FOR FURTHER INFORMATION CONTACT.

VerDate Jan< 31> 2003 16: 52 Feb 20, 2003 Jkt 200001 PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 E:\ FR\ FM\ 21FEN1. SGM 21FEN1 OPPT 2003 0003 0001 RECEIVED OPPT NCIC 2003 FEB21 AM7: 13 8507 Federal Register / Vol. 68, No. 35 / Friday, February 21, 2003 / Notices B. How Can I Get Copies of This Document and Other Related Information?

1. Docket. EPA has established an official public docket for this action under docket identification ( ID) number OPPT   2003   0003. The official public docket consists of the documents specifically referenced in this action, any public comments received, and other information related to this action. Although a part of the official docket, the public docket does not include Confidential Business Information ( CBI) or other information whose disclosure is restricted by statute. The official public docket is the collection of materials that is available for public viewing at the EPA Docket Center, Rm. B102   Reading Room, EPA West, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket Center is open from 8: 30 a. m. to 4: 30 p. m., Monday through Friday, excluding legal holidays. The EPA Docket Center Reading Room telephone number is ( 202) 566   1744 and the telephone number for the OPPT Docket, which is located in EPA Docket Center, is ( 202) 566   0280. 2. Electronic access. You may access this Federal Register document electronically through the EPA Internet under the `` Federal Register'' listings at http:// www. epa. gov/ fedrgstr/. An electronic version of the public docket is available through EPA's electronic public docket and comment system, EPA Dockets. You may use EPA Dockets at http:// www. epa. gov/ edocket/ to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I. B. 1. Once in the system, select `` search,'' then key in the appropriate docket ID number.

II. Meeting Procedures For additional information on the scheduled meeting, the agenda of the NAC/ AEGL Committee, or the submission of information on chemicals to be discussed at the meeting, contact the DFO listed under FOR FURTHER INFORMATION CONTACT. The meeting of the NAC/ AEGL Committee will be open to the public. Oral presentations or statements by interested parties will be limited to 10 minutes. Interested parties are encouraged to contact the DFO technical information contact, to schedule presentations before the NAC/ AEGL Committee. Since seating for outside observers may be limited, those wishing to attend the meeting as observers are also encouraged to contact the DFO at the earliest possible date to ensure adequate seating arrangements. Inquiries regarding oral presentations and the submission of written statements or chemical specific information should be directed to the DFO.

III. Future Meetings Another meeting of the NAC/ AEGL Committee is scheduled for June 2003 in Washington, DC.

List of Subjects Environmental protection, Chemicals, Hazardous substances, Health.

Dated: February 13, 2003. Charles M. Auer, Director, Office of Pollution Prevention and Toxics. [ FR Doc. 03   4244 Filed 2   20   03; 11: 31 am]

BILLING CODE 6560   50   S ENVIRONMENTAL PROTECTION AGENCY [ FRL   7454   3]

National Advisory Council on Environmental Policy and Technology ( NACEPT); Superfund Subcommittee Meeting AGENCY: Environmental Protection Agency ( EPA). ACTION: Notification of public advisory NACEPT subcommittee on Superfund; open meeting.

SUMMARY: Pursuant to the Federal Advisory Committee Act, Pub. L. 92   463, notices is hereby given that the Superfund Subcommittee, a subcommittee of the National Advisory Council on Environmental Policy and Technology ( NACEPT), will meet on the date and time described below. The meeting is open to the public. Seating will be on a first come basis and limited time will be provided for public comment on each day. DATES: The meeting will be held from 1: 30 p. m. to 7 p. m. on March 10, 2003; from 8 a. m. to 5: 30 p. m. on March 11, 2003. ADDRESSES: The meeting will take place at the Phoenix Pointe Hilton Squaw Peak Resort, 7677 North 16th Street Phoenix, AZ 85020. FOR FURTHER INFORMATION CONTACT: Angelo Carasea, Designated Federal Officer for the NACEPT Superfund Subcommittee, Office of Emergency and Remedial Response, Office of Solid Waste and Emergency Response, MC 5204G, 1200 Pennsylvania Ave., NW., Washington, DC, ( 703) 603   8828.

SUPPLEMENTARY INFORMATION:

Agenda This fourth meeting of the Superfund Subcommittee will involve reports from the Subcommittee's working groups about their activities since the last Subcommittee meeting in January 2003. The agenda for the meeting will be available one week prior to the meeting's occurrence.

Public Attendance The public is welcome to attend all portion of the meeting. Members of the public who plan to file written statements and/ or make brief ( suggested 5 minute limit) oral statements at the public sessions are encouraged to contact the Designated Federal Official. Each day will have one public comment period.

Dated: February 14, 2003. Angelo Carasea, Designated Federal Officer, NACEPT Superfund Subcommittee. [ FR Doc. 03   4307 Filed 2   20   03; 8: 45 am]

BILLING CODE 6560   50   P FARM CREDIT ADMINISTRATION Farm Credit Administration Board; Special Meeting AGENCY: Farm Credit Administration. SUMMARY: Notice is hereby given, pursuant to the Government in the Sunshine Act ( 5 U. S. C. 552b( e)( 3)), of the special meeting of the Farm Credit Administration Board ( Board). Date and Time: The special meeting of the Board will be held at the offices of the Farm Credit Administration in McLean, Virginia, on February 19, 2003, from 9 a. m. until such time as the Board concludes its business.

FOR FURTHER INFORMATION CONTACT: Jeanette C. Brinkley, Secretary to the Farm Credit Administration Board, ( 703) 883   4009, TTY ( 703) 883   4056. ADDRESSES: Farm Credit Administration, 1501 Farm Credit Drive, McLean, Virginia 22102   5090.

SUPPLEMENTARY INFORMATION: Parts of this meeting of the Board will be open to the public ( limited space available), and parts will be closed to the public. In order to increase the accessibility to Board meetings, persons requiring assistance should make arrangements in advance. The matters to be considered at the meeting are:

VerDate Jan< 31> 2003 16: 52 Feb 20, 2003 Jkt 200001 PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 E:\ FR\ FM\ 21FEN1. SGM 21FEN1


 [Federal Register Volume 76, Number 130 (Thursday, July 7, 2011)] [Notices] [Page 39868] [FR Doc No: 2011-17003]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER11-3913-000]

AES Thames, L.L.C.; Supplemental Notice That Initial Market-Based

Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding of

AES Thames, LLC's application for market-based rate authority, with an

accompanying rate tariff, noting that such application includes a

request for blanket authorization, under 18 CFR part 34, of future

issuances of securities and assumptions of liability.

    Any person desiring to intervene or to protest should file with the

Federal Energy Regulatory Commission, 888 First Street, NE.,

Washington, DC 20426, in accordance with Rules 211 and 214 of the

Commission's Rules of Practice and Procedure (18 CFR 385.211 and

385.214). Anyone filing a motion to intervene or protest must serve a

copy of that document on the Applicant.

    Notice is hereby given that the deadline for filing protests with

regard to the applicant's request for blanket authorization, under 18

CFR part 34, of future issuances of securities and assumptions of

liability, is July 19, 2011.

    The Commission encourages electronic submission of protests and

interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet

access who will eFile a document and/or be listed as a contact for an

intervenor must create and validate an eRegistration account using the

eRegistration link. Select the eFiling link to log on and submit the

intervention or protests.

    Persons unable to file electronically should submit an original and

14 copies of the intervention or protest to the Federal Energy

Regulatory Commission, 888 First Street, NE., Washington, DC 20426.

    The filings in the above-referenced proceeding are accessible in

the Commission's eLibrary system by clicking on the appropriate link in

the above list. They are also available for review in the Commission's

Public Reference Room in Washington, DC. There is an eSubscription link

on the Web site that enables subscribers to receive e-mail notification

when a document is added to a subscribed docket(s). For assistance with

any FERC Online service, please e-mail<EMAIL_ADDRESS>or

call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: June 30, 2011.

Kimberly D. Bose,

Secretary.

[FR Doc. 2011-17003 Filed 7-6-11; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 169 (Thursday, August 30, 2018)]
[Notices]
[Pages 44274-44277]
[FR Doc No: 2018-18801]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-0049]

Complex Innovative Designs Pilot Meeting Program

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The sixth iteration of the Prescription Drug User Fee Act
(PDUFA VI), incorporated as part of the FDA Reauthorization Act of 2017
(FDARA), highlights the goal of facilitating and advancing the use of
complex adaptive, Bayesian, and other novel clinical trial designs. The
Food and Drug Administration (FDA or Agency) is announcing a pilot
meeting program that affords sponsors who are selected the opportunity
to meet with Agency staff to discuss the use of complex innovative
trial design (CID) approaches in medical product development. Meetings
under the pilot program will be conducted by FDA's Center for Drug
Evaluation and Research (CDER) or Center for Biologics Evaluation and
Research (CBER) during fiscal years 2018 to 2022. This pilot meeting
program fulfills FDA's commitment under PDUFA VI. For each sponsor
whose meeting request is granted as part of the pilot, FDA will grant
two meetings between the sponsor and CDER or CBER that will provide an
opportunity for medical product developers and FDA to discuss
regulatory approaches for CID. To promote innovation in this area,
trial designs developed through the pilot meeting program may be
presented by FDA (e.g., in a guidance or public workshop) as case
studies, including

trial designs for drugs that have not yet been approved by FDA.

DATES: The CID pilot meeting program will proceed from the date of this
notice through September 30, 2022. Sponsors may submit meeting requests
for the pilot program through June 30, 2022. Comments about this pilot
meeting program can be submitted until October 1, 2018. Please note
that late, untimely filed comments will not be considered.

ADDRESSES: You may submit comments about the CID pilot meetings program
as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-0049 for ``Complex Innovative Designs Pilot Meeting
Program.'' Received comments will be placed in the docket and, except
for those submitted as ``Confidential Submissions,'' publicly viewable
at https://www.regulations.gov or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT:
    CDER: Scott Goldie, Center for Drug Evaluation and Research, Food
and Drug Administration, 10903 New Hampshire Ave., Bldg. 21, Rm 3557,
Silver Spring, MD 20993-0002,<PHONE_NUMBER>, [email protected],
with the subject line ``CID Pilot Meeting Program for CDER.''
    CBER: Christopher Egelebo, Center for Biologics Evaluation and
Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
71, Rm 1043, Silver Spring, MD 20993-0002,<PHONE_NUMBER>,
[email protected], with the subject line ``CID Pilot
Meeting Program for CBER.''

SUPPLEMENTARY INFORMATION:

I. Background

    In connection with the sixth iteration of PDUFA, FDA committed to
conduct a pilot program for highly innovative trial designs for which
analytically derived properties (e.g., Type I error) may not be
feasible, and simulations are necessary to determine trial operating
characteristics. The Agency also committed to issue a Federal Register
Notice announcing the pilot program, clarifying pilot program
eligibility, and describing the proposal submission and selection
process (see PDUFA Reauthorization Performance Goals and Procedures
Fiscal Years 2018 Through 2022, section I.J.4.b. (https://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM511438.pdf)).
    FDA is announcing this pilot meeting program to satisfy the above-
mentioned commitments. The goal of the early meeting discussions
granted under this pilot program is to provide advice on how a proposed
CID approach can be used in a specific drug development program and to
promote innovation by allowing FDA to publicly present the trial
designs considered through the pilot program, including trial designs
for drugs that have not yet been approved by FDA. FDA has committed to
accepting up to two meeting requests quarterly each fiscal year.
    Meeting requests may be submitted on a rolling basis; however, only
those requests received by the quarterly closing date, which will be
the last day of each quarter of the fiscal year (i.e., December 31,
March 31, June 30, September 30), will be considered for selection in
the following quarter. Within 45 days after the quarterly closing date,
FDA will review the submissions, select up to four meeting requests
each quarter, two primary and two alternates to proceed to disclosure
discussions, and notify sponsors of their status. If FDA and the
sponsor of a meeting request selected as primary are unable to reach an
agreement on the elements for public disclosure, the Agency will
proceed with an alternate submission. When disclosure discussions are
complete, FDA will grant up to two meetings per quarter under the
pilot.
    The meetings granted will include an initial and followup meeting
on the same CID and medical product within the span of approximately
120 days. Being granted a meeting as part of the pilot meeting program
does not mean that the proposed CID is appropriate for

regulatory decision making. Likewise, being denied a meeting as part of
the pilot meeting program does not mean that the proposed CID is
unacceptable for regulatory decision making. Sponsors who do not
participate in the pilot program may seek Agency interaction on their
clinical development plan through existing channels (e.g., Type C
meeting requests, Critical Path Innovation Meetings).
    The listed eligibility factors and procedures outlined in this
Federal Register notice reflect the current thinking at the time of
publication. Processes may be revised as this pilot program evolves and
will be communicated on the CID Pilot Meeting Program website: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM617212.htm.

II. Eligibility and Selection for Participation in the CID Pilot
Meeting Program

    To be eligible for the CID Pilot Meeting Program:
     The sponsor must have a pre-IND or IND number for the
medical product(s) included in the CID proposal with the intent of
implementing the CID in the pilot program application.
     The proposed CID is intended to provide substantial
evidence of effectiveness to support regulatory approval of the medical
product.
     The trial is not a first in human study, and there is
sufficient clinical information available to inform the proposed CID.
     The sponsor and FDA are able to reach agreement on the
trial design information to be publicly disclosed.
    Recognizing that the FDA will learn both from the number and types
of submissions received, FDA welcomes submissions related to any
eligible CID. However, given that the Agency expects to grant up to two
meeting requests per quarter as part of the pilot program, the Agency
currently intends to select requests based on the following:
     Innovative features of the trial design, particularly if
the innovation may provide advantages over alternative approaches.
Initial priority will be given to trial designs for which analytically
derived properties (e.g., type I error) may not be feasible and
simulations are necessary to determine operating characteristics.
     Therapeutic need (i.e., therapies being developed for use
in disease areas where there are no or limited treatments).

III. Procedures and Submission Information

A. General Information

    The CID pilot meeting program will be jointly administered by the
following centers:
     CDER: CDER's Office of Biostatistics, in the Office of
Translational Sciences, which is the point of contact for all
communications for CDER products.
     CBER: CBER's Office of Biostatistics and Epidemiology,
which is the point of contact for all communications for CBER products.

B. How To Submit a Meeting Request and Meeting Package

    Meeting requests should be submitted electronically to the relevant
application (i.e., pre-IND, IND) with ``CID Pilot Program Meeting
Request for CDER'' (CDER applications) or ``CID Pilot Program Meeting
Request for CBER'' (CBER applications) in the subject line. Information
about providing regulatory submissions in electronic format is
available at: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/%20ElectronicSubmissions/ucm153574.htm.

C. Content and Format of the Meeting Request

    Include the following information in the meeting request (25 pages
or less):
    1. Product name.
    2. Application number.
    3. Proposed indication(s) or context of product development.
    4. A background section that includes a brief history of the
development program and the status of product development.
    5. Trial objectives.
    6. Brief rationale for the choice of the proposed CID.
    7. Description of study design, including study schema with
treatment arms, randomization strategy, and endpoints.
    8. Key features of the statistical analysis plan including, but not
limited to, the analyses, models, analysis population, approach to
handle missing data, and decision criteria. These should include
aspects of the design that may be modified and the corresponding rules
for decisions, if adaptive.
    9. Simulation plan, including the set of parameter configurations
that will be used for the scenarios to be simulated and preliminary
evaluation and discussion of design operating characteristics.
Preliminary simulation results of the operating characteristics (e.g.,
type 1 error, power, etc.) should include several hypothetical,
plausible scenarios.
    10. Elements of the study design that the sponsor considers non-
disclosable, along with a rationale for exclusion.
    11. A list of issues for discussion with the Agency about the
specific CID proposed approach for the applicable drug development
program and a summarized list of next steps in the regulatory decision
making process along with any supporting data relevant to the
discussion.

D. Content and Format of the Meeting Information Package

    Sponsors whose meeting requests are granted as part of the pilot
program should submit a meeting information package electronically with
``CID Pilot Program Meeting Package for CDER'' (CDER applications) or
``CID Pilot Program Meeting Package for CBER'' (CBER applications) in
the subject line no later than 30 days before the initial meeting and
no later than 90 days before the followup meeting.
    The initial meeting package should include the following
information:
    1. Product name.
    2. Application number.
    3. Proposed agenda, including estimated times needed for discussion
of each agenda item.
    4. List of questions for discussion along with a brief summary of
each question that explains the need or context for the question.
    5. Detailed description of the statistical methodology including,
but not limited to, the analyses, models, analysis population, approach
to handle missing data, and decision criteria.
    6. Detailed simulation report that includes the following:
    a. Example trials in which a small number of hypothetical trials
are described with different conclusions.
    b. Description of the set of parameter configurations used for the
simulation scenarios, including a justification of the adequacy of the
choices.
    c. Simulation results detailing the simulated type I error
probability and power under various scenarios.
    d. Simulation code that is readable, adequately commented on, and
includes the random seeds. The code should preferably be written in
widely-used programming languages such as R or SAS to facilitate the
simulation review.
    7. Overall conclusions including a brief summary of the simulated
operating characteristics based on design features and analyses and a
discussion of the utility of the CID given the simulation results.
    The followup meeting package should include the following
information:
    1. Product name.
    2. Application number.

    3. Updated background section that includes a brief history of the
development program and the status of product development and clinical
data to date, if applicable.
    4. Proposed agenda, including estimated times needed for discussion
of each agenda item.
    5. List of questions for discussion with a brief summary of each
question that explains the need or context for the question.
    6. Updated programs/shells for simulations, if applicable.
    7. Summary of new information that is available to support
discussions.

E. Meeting Summaries

    A meeting summary will be sent to the sponsor within 60 days of
each meeting.

F. Disclosure

    To promote innovation and to provide better clarity on the
acceptance of different types of trial designs, trial designs developed
through the pilot program may be presented by FDA (e.g., in a guidance
or public workshop) as case studies, including while the drug studied
in the trial has not yet been approved by FDA. Accordingly, before FDA
grants the initial meeting under this pilot program, FDA and the
sponsor must agree on the information that FDA may include in these
public case studies. The specific information to be disclosed will
depend on the content of each application, but FDA intends to focus on
information that is beneficial to advancing the use of CIDs, and those
elements relevant to the understanding of the CID and its potential use
in a clinical trial intended to support regulatory approval. Generally,
the Agency does not anticipate that the case studies will need to
include information such as molecular structure, the sponsor's name,
product name, subject-level data, recruitment strategies, adverse
events, or a complete description of study eligibility criteria. FDA
does anticipate that the following information will generally need to
be disclosed to facilitate discussion of the proposed CID: Study
endpoints to the degree necessary to describe the design (e.g., overall
survival in the context of a time to event analysis), target
population, sample size and power determination, null and alternative
hypotheses, key operating characteristics, assumed rates for
dichotomous outcomes or mean and variance for continuous outcomes,
simulation objectives, simulation scenarios, assumptions (e.g., dropout
rate, rate of enrollment), modeling characteristics, critical study
design characteristics including any adaptive elements (e.g., decision
criteria to add/drop a dose, etc.), and, if a Bayesian approach, how
Bayesian methods are being used for design and/or analysis purposes.
    It is important that sponsors wishing to participate in the pilot
program identify aspects of the design and analysis that they consider
non-disclosable and provide a rationale for withholding the
information. Participation in the pilot program, including any
agreement on information disclosure, will be voluntary and at the
discretion of the sponsor. Sponsors that do not wish to make such
disclosures may seek regulatory input through other existing channels.

IV. Paperwork Reduction Act of 1995

    This notice refers to collections of information that are subject
to review by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collection
of information resulting from formal meetings between sponsors or
applicants and FDA has been approved under OMB control number 0910-
0429. The collection of information in 21 CFR part 312 (investigational
new drug applications) has been approved under OMB control number 0910-
0014.

    Dated: August 24, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-18801 Filed 8-29-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: June 23, 2009 (Volume 74, Number 119)]
[Notices]
[Page 29686]
[DOCID:fr23jn09-41]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. ER06-615-000; ER07-1257-000; ER08-1113-000; ER08-1178-000;
ER09-241-000]

California Independent System Operator Corporation; Notice of
FERC Staff Attendance

June 16, 2009.
    The Federal Energy Regulatory Commission (Commission) hereby gives
notice that on the following dates members of its staff will
participate in teleconferences and meetings to be conducted by the
California Independent System Operator (CAISO). The agenda and other
documents for the teleconferences and meetings are available on the
CAISO's Web site, http://www.caiso.com.

----------------------------------------------------------------------------------------------------------------

----------------------------------------------------------------------------------------------------------------
June 17, 2009................................  Settlements and Market Clearing User Group.
                                               Congestion Revenue Rights.
                                               Meeting of Market Surveillance Committee.
June 18, 2009................................   Market Issues.
June 19, 2009................................   Market Initiatives Roadmap.
June 23, 2009................................   Systems Interface User Group.
                                               BPM Change Management.
June 24, 2009................................  Congestion Revenue Rights.
                                               Settlements and Market Clearing User Group.
                                               Release Planning Workshop.
June 25, 2009................................   Market Issues.
June 26, 2009................................  Participating Intermittent Resource Program.
June 30, 2009................................   Systems Interface User Group.
                                               Comparable Treatment of Generation and non Generation for
                                                Ancillary Services.
----------------------------------------------------------------------------------------------------------------

    Sponsored by the CAISO, the teleconferences and meetings are open
to all market participants, and Commission staff's attendance is part
of the Commission's ongoing outreach efforts. The teleconferences and
meetings may discuss matters at issue in the above captioned dockets.
    For further information, contact Saeed Farrokhpay at
<EMAIL_ADDRESS>(916) 294-0322 or Maury Kruth at
<EMAIL_ADDRESS>(916) 294-0275.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-14654 Filed 6-22-09; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 39 (Monday, February 29, 2016)]
[Rules and Regulations]
[Pages 10070-10072]
[FR Doc No: 2016-04137]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2015-3633; Directorate Identifier 2014-NM-097-AD;
Amendment 39-18416; AD 2016-04-22]
RIN 2120-AA64

Airworthiness Directives; Fokker Services B.V. Airplanes

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: We are adopting a new airworthiness directive (AD) for all
Fokker Services B.V. Model F.27 Mark 200, 300, 400, 500, 600, and 700
airplanes. This AD was prompted by a design review conducted by Fokker
Services B.V. that indicated no controlled bonding provisions were
present on many critical locations outside the fuel tank or connected
to the fuel tank wall. This AD requires installing the additional
bonding provisions, and revising the maintenance or inspection program,
as applicable, by incorporating fuel airworthiness limitation items and
critical design configuration control limitations. We are issuing this
AD to prevent an ignition source in the fuel tank vapor space, which
could result in a fuel tank explosion and consequent loss of the
airplane.

DATES: This AD becomes effective April 4, 2016.
    The Director of the Federal Register approved the incorporation by
reference of certain publications listed in this AD as of April 4,
2016.

ADDRESSES: For service information identified in this final rule,
contact Fokker Services B.V., Technical Services Dept., P.O. Box 1357,
2130 EL Hoofddorp, the Netherlands; telephone +31 (0)88-6280-350; fax
+31 (0)88-6280-111; email<EMAIL_ADDRESS>Internet http://www.myfokkerfleet.com. You may view this referenced service
information at the FAA, Transport Airplane Directorate, 1601 Lind
Avenue SW., Renton, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>. It is also available on the
Internet at http://www.regulations.gov by searching for and locating
Docket No. FAA-2015-3633.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2015-
3633; or in person at the Docket Management Facility between 9 a.m. and
5 p.m., Monday through Friday, except Federal holidays. The AD docket
contains this AD, the regulatory evaluation, any comments received, and
other information. The street address for the Docket Operations office
(telephone<PHONE_NUMBER>) is in the ADDRESSES section.

FOR FURTHER INFORMATION CONTACT: Tom Rodriguez, Aerospace Engineer,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
1601 Lind Avenue SW., Renton, WA 98057-3356; telephone<PHONE_NUMBER>;
fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Discussion

    We issued a notice of proposed rulemaking (NPRM) to amend 14 CFR
part 39 by adding an AD that would apply to all Fokker Services B.V.
Model F.27 Mark 200, 300, 400, 500, 600, and 700 airplanes. The NPRM
published in the Federal Register on September 18, 2015 (80 FR 56413)
(``the NPRM'').
    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Union, has issued EASA
Airworthiness Directive 2014-0100, dated April 30, 2014 (referred to
after this as the Mandatory Continuing Airworthiness Information, or
``the MCAI''), to correct an unsafe condition for all Fokker Services
B.V. Model F.27 Mark 200, 300, 400, 500, 600, and 700 airplanes. The
MCAI states:

    Prompted by an accident * * *, the FAA published Special Federal
Aviation Regulation (SFAR) 88 [(66 FR 23086, May 7, 2001)], and the
Joint Aviation Authorities (JAA) published Interim Policy INT/POL/
25/12.
    The review conducted by Fokker Services on the Fokker 27 design
in response to these regulations revealed that no controlled

bonding provisions are present on a number of critical locations
outside the fuel tanks.
    This condition, if not corrected, could create an ignition
source in the fuel tank vapour space, possibly resulting in a fuel
tank explosion and consequent loss of the aeroplane.
    To address this potential unsafe condition, Fokker Services
developed a set of bonding modifications, introduced with [a service
bulletin] * * *, that do[es] not require opening of the fuel tank
access panels.
    More information on this subject can be found in Fokker Services
All Operators Message AOF27.043#03.
    For the reasons described above, this [EASA] AD requires
installation of additional bonding provisions that do not require
opening of the fuel tank access panels.

    Required actions also include revising the maintenance or
inspection program, as applicable, by incorporating fuel airworthiness
limitation items and critical design configuration control limitations.
You may examine the MCAI in the AD docket on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2015-
3633.

Comments

    We gave the public the opportunity to participate in developing
this AD. We received no comments on the NPRM or on the determination of
the cost to the public.

Conclusion

    We reviewed the relevant data and determined that air safety and
the public interest require adopting this AD as proposed except for
minor editorial changes. We have determined that these minor changes:
     Are consistent with the intent that was proposed in the
NPRM for correcting the unsafe condition; and
     Do not add any additional burden upon the public than was
already proposed in the NPRM.

Related Service Information Under 1 CFR Part 51

    Fokker Services B.V. has issued Fokker F27 Proforma Service
Bulletin SBF27-28-072, Revision 1, dated March 6, 2014, including
Fokker F27 Service Bulletin Appendix SBF27-28-072/APP01, dated July 17,
2014, including List of Drawings/Part Lists, dated July 17, 2014. The
service information describes procedures for installing additional
bonding provisions.
    Fokker Services B.V. has also issued Fokker Manual Change
Notification--Maintenance Documentation MCNM-F27-027, dated September
9, 2014. The service information describes fuel airworthiness
limitations items and critical design configuration control
limitations.
    This service information is reasonably available because the
interested parties have access to it through their normal course of
business or by the means identified in the ADDRESSES section.

Costs of Compliance

    We estimate that this AD affects 15 airplanes of U.S. registry.
    We also estimate that it will take about 8 work-hours per product
to comply with the basic requirements of this AD. The average labor
rate is $85 per work-hour. Based on these figures, we estimate the cost
of this AD on U.S. operators to be $10,200, or $680 per product.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this AD will not have federalism implications
under Executive Order 13132. This AD will not have a substantial direct
effect on the States, on the relationship between the national
government and the States, or on the distribution of power and
responsibilities among the various levels of government.
    For the reasons discussed above, I certify that this AD:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979);
    3. Will not affect intrastate aviation in Alaska; and
    4. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

Adoption of the Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

2016-04-22 Fokker Services B.V.: Amendment 39-18416. Docket No. FAA-
2015-3633; Directorate Identifier 2014-NM-097-AD.

(a) Effective Date

    This AD becomes effective April 4, 2016.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Fokker Services B.V. Model F.27 Mark 200,
300, 400, 500, 600, and 700 airplanes, certificated in any category,
all serial numbers.

(d) Subject

    Air Transport Association (ATA) of America Code 28, Fuel.

(e) Reason

    This AD was prompted by a design review conducted by Fokker
Services B.V. that indicated no controlled bonding provisions were
present on many critical locations outside the fuel tank or
connected to the fuel tank wall. We are issuing this AD to prevent
an ignition source in the fuel tank vapor space, which could result
in a fuel tank explosion and consequent loss of the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Installation

    Within 24 months after the effective date of this AD, install
additional bonding provisions, in accordance with the Accomplishment
Instructions of Fokker F27 Proforma Service Bulletin SBF27-28-072,
Revision 1, dated March 6, 2014, including Fokker F27 Service
Bulletin Appendix SBF27-28-072/APP01, dated July 17, 2014, including
List of Drawings/Part Lists, dated July 17, 2014.

(h) Maintenance or Inspection Program Revision

    At the later of the times specified in paragraphs (h)(1) and
(h)(2) of this AD: Revise the airplane maintenance or inspection
program, as applicable, by incorporating the fuel airworthiness
limitations items and critical design configuration control
limitations as identified in Fokker Manual Change Notification--
Maintenance Documentation MCNM-F27-027, dated September 9, 2014.
    (1) Before further flight after accomplishing the installation
required by paragraph (g) of this AD,
    (2) Within 30 days after the effective date of this AD.

(i) No Alternative Actions, Intervals, and/or Critical Design
Configuration Control Limitations (CDCCLs)

    After the maintenance or inspection program, as applicable, has
been revised as required by paragraph (h) of this AD, no alternative
actions (e.g., inspections), intervals, and/or CDCCLs may be used
unless the actions, intervals, and/or CDCCLs are approved as an
alternative method of compliance in accordance with the procedures
specified in paragraph (j)(1) of this AD.

(j) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
has the authority to approve AMOCs for this AD, if requested using
the procedures found in 14 CFR 39.19. In accordance with 14 CFR
39.19, send your request to your principal inspector or local Flight
Standards District Office, as appropriate. If sending information
directly to the International Branch, send it to ATTN: Tom
Rodriguez, Aerospace Engineer, International Branch, ANM-116,
Transport Airplane Directorate, FAA, 1601 Lind Avenue SW., Renton,
WA 98057-3356; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER> Information
may be emailed to<EMAIL_ADDRESS>Before using any
approved AMOC, notify your appropriate principal inspector, or
lacking a principal inspector, the manager of the local flight
standards district office/certificate holding district office. The
AMOC approval letter must specifically reference this AD.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain corrective actions from a manufacturer, the action must be
accomplished using a method approved by the Manager, International
Branch, ANM-116, Transport Airplane Directorate, FAA; or the
European Aviation Safety Agency (EASA); or Fokker B.V. Service's
EASA Design Organization Approval (DOA). If approved by the DOA, the
approval must include the DOA-authorized signature.

(k) Related Information

    Refer to Mandatory Continuing Airworthiness Information (MCAI)
EASA Airworthiness Directive 2014-0100, dated April 30, 2014, for
related information. This MCAI may be found in the AD docket on the
Internet at http://www.regulations.gov by searching for and locating
Docket No. FAA-2015-3633.

(l) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference (IBR) of the service information listed
in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless this AD specifies otherwise.
    (i) Fokker F27 Proforma Service Bulletin SBF27-28-072, Revision
1, dated March 6, 2014, including Fokker F27 Service Bulletin
Appendix SBF27-28-072/APP01, dated July 17, 2014, including List of
Drawings/Part Lists, dated July 17, 2014.
    (ii) Fokker Manual Change Notification--Maintenance
Documentation MCNM-F27-027, dated September 9, 2014.
    (3) For service information identified in this AD, contact
Fokker Services B.V., Technical Services Dept., P.O. Box 1357, 2130
EL Hoofddorp, the Netherlands; telephone +31 (0)88-6280-350; fax +31
(0)88-6280-111; email<EMAIL_ADDRESS>Internet http://www.myfokkerfleet.com.
    (4) You may view this service information at the FAA, Transport
Airplane Directorate, 1601 Lind Avenue SW., Renton, WA. For
information on the availability of this material at the FAA, call
425-227-1221.
    (5) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, call<PHONE_NUMBER>, or go to: http://www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued in Renton, Washington, on February 18, 2016.
Dionne Palermo,
Acting Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2016-04137 Filed 2-26-16; 8:45 am]
 BILLING CODE 4910-13-P